Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Enoximone in Acute Exacerbation COPD

NCT04420455 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT04420455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Enoximone in Acute Exacerbation COPD
Lead sponsor
Rijnstate Hospital
Phase
Phase 4
Overall status
Terminated
Start date
May 12, 2020
Completion date
December 21, 2021
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation, enoximone, phosphodiesterase inhibitor